Top 10 Companies in Europe in 2021 by Pipeline Products

Roche Diagnostics International Ltd, Medtronic Plc, Qiagen NV, Siemens Healthineers AG, and Adaltis Srl are the top 5 Companies in Europe in 2021 by pipeline products. Cumulatively, the top Companies in Europe reported pipeline products of 804, the highest number of pipeline products was reported by Roche Diagnostics International Ltd (238), followed by Medtronic Plc (111) and Qiagen NV (94), while Novartis AG (33) stood the lowest. In terms of the geographical split, 7 out of 10 Companies are based in Europe, while 3 are based in Asia. They employed a total of 284,845 people in 2021. Switzerland -based Roche Diagnostics International Ltd is the leading company in Europe in 2021 by pipeline products (FY 2021). It provides diagnostic system solutions to clinics, laboratories, and doctors’ offices. Its major products include instruments and software systems, diagnostic analysis systems and workflow solutions, and molecular diagnostic reagents and test systems. The company reported 238 pipeline products and generated revenue of $19,431 million. The company operates through four business units: Centralized and Point of Care Solutions, Molecular Diagnostics, Diabetes Care, and Tissue Diagnostics in Europe, the Middle East, Africa, Latin America, North America, Asia-Pacific, and Japan, and employs 2,600 people. Ireland-based Medtronic Plc is one of the leading companies in Europe in 2021 by pipeline products (FY 2021). It is a medical technology company that designs, develops, manufactures, and markets a wide range of medical devices and solutions. It offers products for the treatment of heart valve disorders, heart failure, diseases of the coronary artery, aortic, peripheral vascular, venous renal and neurological diseases, spine and musculoskeletal disorders, and diseases of the ear, nose, and throat. The company reported 111 marketed products and generated revenue of $30,117 million, with average revenue growth of 4.16% primarily due to the recovery of global procedural sales resulting from the pandemic and increased sales of Cardiac Rhythm Management and Cardiac Ablation Solutions products. The company operates through four reportable segments: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes Operating Unit, and operates through 350 locations in over 150 countries and employs 95,000 people.